TNFSF10 and squamous cell carcinoma: A recent report examining the combined effects of bortezomib and TRAIL on 15 different squamous cell carcinoma lines found that bortezomib also enhanced TRAIL efficacy through increased recruitment of caspase 8 and FADD into the DISC, and augmentation of the intrinsic apoptotic pathway [63].